180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical TrialGlobeNewsWire • 12/01/21
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren SymposiumGlobeNewsWire • 11/18/21
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business OfficerGlobeNewsWire • 11/03/21
180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal MoleculesGlobeNewsWire • 10/26/21
Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongoing Supply of Drug for Anti-TNF Product Trials for Novel IndicationsGlobeNewsWire • 09/20/21
180 Life Sciences: Looking At Inflammation With Cannabis (Podcast Transcript)Seeking Alpha • 09/13/21
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to StockholdersGlobeNewsWire • 08/30/21
180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)GlobeNewsWire • 07/12/21
180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-KGlobeNewsWire • 06/28/21
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of DirectorsGlobeNewsWire • 06/10/21
180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of DirectorsGlobeNewsWire • 05/28/21
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-QGlobeNewsWire • 05/21/21
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-KGlobeNewsWire • 04/19/21